Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TREMELIMUMAB Cause Hepatic failure? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hepatic failure have been filed in association with TREMELIMUMAB (IMJUDO). This represents 0.4% of all adverse event reports for TREMELIMUMAB.

10
Reports of Hepatic failure with TREMELIMUMAB
0.4%
of all TREMELIMUMAB reports
9
Deaths
4
Hospitalizations

How Dangerous Is Hepatic failure From TREMELIMUMAB?

Of the 10 reports, 9 (90.0%) resulted in death, 4 (40.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.

Is Hepatic failure Listed in the Official Label?

Yes, Hepatic failure is listed as a known adverse reaction in the official FDA drug label for TREMELIMUMAB.

What Other Side Effects Does TREMELIMUMAB Cause?

Pyrexia (178) Diarrhoea (136) Death (116) Colitis (115) Pneumonitis (87) Pneumonia (85) Sepsis (82) Vomiting (78) Febrile neutropenia (72) Malignant neoplasm progression (68)

What Other Drugs Cause Hepatic failure?

ACETAMINOPHEN (1,392) RIBAVIRIN (888) CYCLOPHOSPHAMIDE (629) METHOTREXATE (598) BEVACIZUMAB (558) SOFOSBUVIR (525) RITUXIMAB (513) VINCRISTINE (468) DOXORUBICIN (462) PREDNISOLONE (425)

Which TREMELIMUMAB Alternatives Have Lower Hepatic failure Risk?

TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL TREMELIMUMAB vs TRENBOLONE TREMELIMUMAB vs TREOSULFAN TREMELIMUMAB vs TREPROSTINIL TREMELIMUMAB vs TREPROSTINIL DIOLAMINE

Related Pages

TREMELIMUMAB Full Profile All Hepatic failure Reports All Drugs Causing Hepatic failure TREMELIMUMAB Demographics